Skip to main content

NIR-OGT-201 A Phase 2 trial of Nirogacestat in Patients with Recurrent Ovarian Granulosa
Cell Tumors

NCT05348356

A Phase 2 trial of Nirogacestat in Patients with Recurrent Ovarian Granulosa
Cell Tumors

Principal Investigator

Robert Holloway

Sponsor

SpringWorks Therapeutics

You are being asked to take part in a clinical research study because you have a rare type of ovarian cancer known as ovarian granulosa cell tumor (also known as sex cord-stromal tumor). A person who takes part in a research study is called a research participant.